Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study (COGRare5)

March 9, 2026 updated by: Hospices Civils de Lyon

A National Prospective Cohort for Pregnancies in Patients With Rare Vascular Anomalies: COGRare5 Study

There are no prospective studies of pregnancies for the diseases studied here in (Heredity Hemorrhagic Telangiectasia, Marfan syndrome or related, primary lower limb lymphedema, superficial arteriovenous malformations, and cerebro-spinal arteriovenous malformations) although complications of these can present life-threatening health problems for the mother and her baby.

The purpose of this National prospective study is to obtain greater insight into obstetrical complications associated with rare maternal vascular genetic disorders in order to improve prevention and to reduce risk of death.

In this context, experts and patient associations consider that there is a need to make real progress in the formulation of recommendations based on scientific data.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • France
      • Angers, France, 49933
        • Recruiting
        • Service de Médecine Interne et Maladies Vasculaires + Service Neuropédiatrie et neurochirurgie de l'enfant - CHU Angers
        • Contact:
        • Contact:
      • Bordeaux, France, 33075
        • Withdrawn
        • Service de Médecine interne et immunologie clinique + Service de Médecine Vasculaire - Hôpital Saint André, CHU de Bordeaux
      • Boulogne-Billancourt, France, 92104
        • Recruiting
        • Service Pneumologie et Oncologie Thoracique - AP-HP Hôpital Ambroise Paré
        • Contact:
        • Principal Investigator:
          • Sandra BLIVET, MD
      • Bron, France, 69677
        • Recruiting
        • Centre de Référence pour la maladie de Rendu-Osler - Service Génétique Clinique - Hôpital Femme-Mère-Enfant - Hospices Civils de Lyon
        • Contact:
        • Contact:
      • Bron, France, 69677
        • Recruiting
        • Service d'Imagerie Pédiatrique et Fœtale et Consultation Pluridisciplinaire des Angiomes - Hôpital Femme-Mère-Enfant - HCL
        • Contact:
      • Bron, France, 69677
        • Recruiting
        • Service de Génétique, Hôpital Femme-Mère-Enfant
        • Contact:
        • Principal Investigator:
          • Alexandre GUILHEM
      • Bron, France, 69677
        • Withdrawn
        • Service d'imagerie médicale - Neuroradiologie interventionnelle - Hôpital Neurologique P. Wertheimer - HCL
      • Caen, France, 14033
        • Recruiting
        • Service de Médecine Vasculaire - Hôpital de la Côte de Nacre
        • Contact:
        • Sub-Investigator:
          • Damien LANEELLE, MD
        • Sub-Investigator:
          • Fabien LABOMBARDA, MD
        • Principal Investigator:
          • Laurent CHAUSSAVOINE, MD
      • Clermont-Ferrand, France, 63000
        • Recruiting
        • Service Médecine Interne Estaing CHU de Clermont-Ferrand - Hôpital d'Estaing
        • Contact:
        • Principal Investigator:
          • Vincent GROBOST, MD
      • Dijon, France
        • Recruiting
        • CHU Dijon Bourgogne - Hopital Francois Mitterrand
        • Contact:
        • Sub-Investigator:
          • Laurence OLIVIER-FAIVRE, MD-PhD
        • Principal Investigator:
          • Vanessa LEGUY-SEGUIN, MD
      • Lille, France, 59037
        • Recruiting
        • Service de Médecine vasculaire et HTA - Hôpital Albert Calmette, CHRU de Lille
        • Contact:
        • Principal Investigator:
          • Pascal DELSART, MD
      • Lille, France, 59037
        • Recruiting
        • Service Médecine interne - CHRU de Lille - Hôpital Claude Huriez
        • Contact:
        • Sub-Investigator:
          • Marc LAMBERT, MD
        • Principal Investigator:
          • Hélène MAILLARD, MD
      • Marseille, France, 13385
        • Recruiting
        • CHU de Marseille - Hôpital de la Timone
        • Contact:
        • Sub-Investigator:
          • Laurence BAL-THEOLEYRE, MD
        • Principal Investigator:
          • Baptiste ANDRE, MD
        • Sub-Investigator:
          • Anthony REYRE, MD-PhD
      • Montpellier, France, 34295
        • Recruiting
        • Service Médecine Interne - Hôpital Saint-Eloi, CHU de Montpellier
        • Contact:
        • Principal Investigator:
          • Sophie RIVIERE, MD
        • Sub-Investigator:
          • Isabelle QUERE, PD-PhD
      • Nancy, France, 54035
        • Recruiting
        • Service de neuroradiologie diagnostique et interventionnelle - CHU de Nancy, Hôpital St-Julien
        • Contact:
        • Principal Investigator:
          • Serge BRACARD, MD-PhD
      • Nantes, France, 44093
        • Recruiting
        • Service de Médecine Interne-Médecine Vasculaire, CHU de Nantes - Hôtel Dieu
        • Contact:
        • Principal Investigator:
          • Olivier ESPITIA, MD
      • Nice, France, 06001
        • Recruiting
        • Unité de neuro-interventionnelle CHU Nice, Hôpital Pasteur 2
        • Contact:
          • Jacques SEDAT, MD
          • Phone Number: +33 04.92.03.38.07
          • Email: nri@chu-nice.fr
        • Principal Investigator:
          • Jacques SEDAT, MD
      • Nice, France, 06202
        • Recruiting
        • Service de dermatologie, CHU de Nice - Hôpital l'Archet 2
        • Principal Investigator:
          • Christine CHIAVERINI, MD
        • Contact:
      • Paris, France, 75010
        • Recruiting
        • Service de Neuroradiologie - AP-HP - Paris (Hôpital Lariboisière)
        • Contact:
        • Principal Investigator:
          • Annouk BISDORFF-BRESSON, MD
      • Paris, France, 75015
        • Recruiting
        • Service de Lymphologie - Hôpital Cognacq-Jay - Paris
        • Principal Investigator:
          • Stéphane VIGNES, MD
        • Contact:
      • Paris, France, 75018
        • Recruiting
        • Service de Cardiologie - Hôpital Bichat, AP-HP
        • Contact:
        • Principal Investigator:
          • Guillaume JONDEAU, MD-PHd
      • Paris, France, 75019
        • Recruiting
        • Service de Neuroradiologie Interventionnelle - Fondation Adolphe de Rothschild
        • Contact:
        • Principal Investigator:
          • Stanislas SMAJDA, MD
      • Paris, France
        • Recruiting
        • Service Radiologie-pneumologie interventionnelle - Hôpital Tenon AP-HP
        • Contact:
        • Principal Investigator:
          • Antoine PARROT, MD
      • Poitiers, France, 86021
        • Recruiting
        • Service de Génétique CHU de Poitiers
        • Contact:
        • Principal Investigator:
          • Xavier LE GUILLOU-HORN, MD
      • Rennes, France, 35033
        • Recruiting
        • Service de Pneumologie CHU de Rennes - Hôpital Pontchaillou
        • Principal Investigator:
          • Mallorie KERJOUAN, MD
        • Contact:
      • Rennes, France, 35203
        • Recruiting
        • Unité de Génétique médicale, CHU de Rennes, Hôpital Sud
        • Contact:
        • Principal Investigator:
          • Sylvie ODENT, MD-PhD
      • Rouen, France, 76000
        • Withdrawn
        • Service Médecine Interne - Médecine vasculaire - CHU de Rouen, Hôpital Charles Nicolle
      • Saint-Etienne, France, 42055
        • Recruiting
        • Service de Médecine Vasculaire et Thérapeutique, Explorations Fonctionnelles Vasculaires - CHU de Saint-Etienne - Hôpital Nord
        • Contact:
        • Principal Investigator:
          • Claire LE HELLO, MD-PhD
      • Saint-Herblain, France, 44800
        • Recruiting
        • Clinique cardiologique et des maladies vasculaires CHU de Nantes, Hôpital G. R. LAENNEC
        • Contact:
        • Principal Investigator:
          • Laurianne LE GLOAN, MD
      • Strasbourg, France, 67091
        • Recruiting
        • Service Maladies vasculaires - HTA - NHC Pôle Médico-chirurgicale cardio-vasculaire, CHU de Strasbourg - Hôpital Civil
        • Contact:
        • Principal Investigator:
          • Dominique STEPHAN, MD-PhD
      • Strasbourg, France, 67200
        • Recruiting
        • CHU de Strasbourg, Hôpital de Hautepierre
        • Contact:
        • Principal Investigator:
          • Murielle RONDEAU-LUTZ, MD
      • Suresnes, France, 92151
        • Recruiting
        • Service de Neuroradiologie Interventionnelle - Hôpital Foch
        • Contact:
        • Principal Investigator:
          • Georges RODESCH, MD
      • Toulouse, France, 31026
        • Recruiting
        • Service de Cardiologie _ Hôpital des Enfants (Purpan)
        • Contact:
        • Principal Investigator:
          • Yves DULAC, MD
      • Toulouse, France, 31059
        • Recruiting
        • Service de Médecine Interne + Service Médecine Vasculaire _ Hôpital RANGUEIL
        • Contact:
        • Contact:
        • Principal Investigator:
          • Laurent ALRIC, MD-PhD
        • Sub-Investigator:
          • Alessandra BURA-RIVIERE, MD-PhD
      • Tours, France, 37044
        • Recruiting
        • Service Pneumologie, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire de TOURS
        • Contact:
        • Principal Investigator:
          • Pascal MAGRO, MD
      • Vandœuvre-lès-Nancy, France, 54511
        • Withdrawn
        • CHU de Nancy - Hôpitaux de Brabois

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

This study describes severe and specific obstetrical complications during and after pregnancy (until 12 months postpartum) for the following pathologies: heredity hemorrhagic telangiectasia, marfan syndrome or related, primary lower limb lymphedema, superficial arteriovenous malformations or even cerebro-spinal arteriovenous malformations.

Description

Inclusion Criteria:

  • Women aged ≥ 18 years and ≤45 years at the time of inclusion
  • Pregnant and/or having given birth less than 1 month (≤ 30 days)
  • Clinically and/or radiological and/or molecular biology diagnosis of a rare vascular disease before or during pregnancy or one month after delivery.
  • Having been informed of all pertinent aspects of the study and provided oral non-opposition.

Exclusion Criteria:

  • Any person not fulfilling the inclusion criteria or refusing to take part in the study.
  • Major under legal protection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Occurrence of obstetrical complications among patients with rare vascular anomalies.
Time Frame: Every 3 months up to 21 months
The primary outcome measure is the occurrence of specific and serious obstetrical complications during the pregnancy period and and after 12 months among patients with rare vascular anomalies, obtained via phone questionnaire.
Every 3 months up to 21 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hospices Civils de Lyon

Investigators

  • Principal Investigator: Sophie DUPUIS-GIROD, MD, Service de Génétique - Hôpital Femme-Mère-Enfant - HCL

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 6, 2020

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

November 1, 2028

Study Registration Dates

First Submitted

December 9, 2019

First Submitted That Met QC Criteria

December 9, 2019

First Posted (Actual)

December 11, 2019

Study Record Updates

Last Update Posted (Actual)

March 11, 2026

Last Update Submitted That Met QC Criteria

March 9, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 69HCL19_0380

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arteriovenous Malformations

Clinical Trials on Questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe